← Back to search

Harmony Biosciences Holdings Inc

HRMY · NASDAQ

Pharmaceutical Preparation Manufacturing

Harmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.

ESG Scores

Overall ESG
4.5
Environmental
2.4
Social
3.3
Governance
5.4

Gender Diversity

Female Directors0.125%
Female Executives0.12371134020618557%
CEO GenderMale

Market Data

Price$36.84+3.34 (+9.97%)
Market Cap
P/E Ratio
EPS$—
52W High$—
52W Low$—
Beta